Literature DB >> 7068593

High and low molecular weight forms of endothelial cell growth factor.

T Maciag, G A Hoover, R Weinstein.   

Abstract

Endothelial cell growth factor (ECGF) is a neural-derived mitogen capable of stimulating the proliferation of quiescent populations of human umbilical vein endothelial cells (HUV-EC). ECGF has been isolated from bovine hypothalamus in two forms: a high molecular weight from (high Mr ECGF, greater than 70,000) and a low molecular weight form form (low Mr ECGF, 17,000 to 25,000). Isoelectric focusing of high Mr ECGF and low Mr ECGF revealed that both Mr forms possess similar anionic isoelectric points (pI 4 to 6). High Mr ECGF can be converted into low Mr ECGF by mild acidification of the high Mr ECGF complex. Low Mr ECGF prepared by the high Mr to low Mr transition procedure is biologically active at 100 ng/ml in the low density HUV-EC growth assay and is capable of stimulating DNA synthesis in Balb/c 3T3 cells at 10 ng/ml. The two Mr forms of ECGF are related since they (i) share similar biological activity, (ii) possess similar isoelectric points, and (iii) high Mr ECGF can be converted into low Mr ECGF by mild treatment with acetic acid. Furthermore, the high Mr and low Mr forms of ECGF are not related to the cationic bovine brain fibroblast growth factor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7068593

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Selective alterations of RNA in rat hippocampus after entorhinal cortex lesioning.

Authors:  J Poirier; P C May; H H Osterburg; J Geddes; C Cotman; C E Finch
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

2.  Quantitative in-vivo studies on angiogenesis in a rat sponge model.

Authors:  S P Andrade; T P Fan; G P Lewis
Journal:  Br J Exp Pathol       Date:  1987-12

3.  Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF.

Authors:  F Esch; A Baird; N Ling; N Ueno; F Hill; L Denoroy; R Klepper; D Gospodarowicz; P Böhlen; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

4.  Mitogenic polypeptide of the mammalian seminiferous epithelium: biochemical characterization and partial purification.

Authors:  L A Feig; M Klagsbrun; A R Bellvé
Journal:  J Cell Biol       Date:  1983-11       Impact factor: 10.539

5.  Brain- and liver cell-derived factors are required for growth of human endothelial cells in serum-free culture.

Authors:  H Hoshi; W L McKeehan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

6.  Characterization and partial purification of an endothelial cell growth factor from human platelets.

Authors:  G L King; S Buchwald
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

7.  Long-term culture of human endothelial cells.

Authors:  P B Gordon; I I Sussman; V B Hatcher
Journal:  In Vitro       Date:  1983-09

8.  Novel cross-talk between three cardiovascular regulators: thrombin cleavage fragment of Jagged1 induces fibroblast growth factor 1 expression and release.

Authors:  Maria Duarte; Vihren Kolev; Doreen Kacer; Carla Mouta-Bellum; Raffaella Soldi; Irene Graziani; Aleksandr Kirov; Robert Friesel; Lucy Liaw; Deena Small; Joseph Verdi; Thomas Maciag; Igor Prudovsky
Journal:  Mol Biol Cell       Date:  2008-09-10       Impact factor: 4.138

9.  Interaction of endothelial cell growth factor with heparin: characterization by receptor and antibody recognition.

Authors:  A B Schreiber; J Kenney; W J Kowalski; R Friesel; T Mehlman; T Maciag
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

10.  Cell proliferation after ischemic injury in gerbil brain. An immunocytochemical and autoradiographic study.

Authors:  M du Bois; P D Bowman; G W Goldstein
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.